Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing the previous v3.2.0. This appears to be a minor update with no changes to the study data or eligibility criteria.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page no longer displays the operating-status notice about government funding. Trial content and study details remain unchanged.SummaryDifference0.4%

- Check38 days agoChange DetectedThe update appears to consist of minor UI refinements and layout adjustments, with no changes to core study content. Core details such as eligibility criteria, outcomes, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedVersion update from v3.0.2 to v3.2.0 indicating a new release; no other content changes detected.SummaryDifference0.1%

- Check69 days agoChange DetectedUpdates the revision tag from v3.0.2 to v3.1.0, indicating a new release version without substantive changes to visible content.SummaryDifference0.1%

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.